Open AccessLymph‐Directed Self‐Immolative Nitric Oxide Prodrug for Inhibition of Intractable Metastatic Cancer (Adv. Sci. 8/2022)
Author(s) -
Kim Taejeong,
Suh Jeeyeon,
Kim Jihoon,
Kim Won Jong
Publication year - 2022
Publication title -
advanced science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.388
H-Index - 100
ISSN - 2198-3844
DOI - 10.1002/advs.202270050
Subject(s) - prodrug , nitric oxide , lymph , drug delivery , chemistry , pharmacology , cancer research , cancer , medicine , drug , pathology , organic chemistry
Lymph‐Directed Drug Delivery In article number 2101935, Jihoon Kim, Won Jong Kim, and co‐workers introduce an albumin‐conjugated self‐immolative nitric oxide (NO) prodrug to achieve lymph‐directed NO delivery for inhibition of tumor metastasis. This novel prodrug can contribute to the on‐demand delivery of NO for biomedical applications.